Similar articles for PMID: 25897233

Year	Number of Results
1996	1
1997	1
2003	1
2005	5
2006	3
2007	3
2008	4
2009	4
2010	4
2011	6
2012	7
2013	7
2014	8
2015	8
2016	9
2017	9
2018	4
2019	6
2020	2
2021	3
2022	3
2024	0

1

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder.

Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J. Atake K, et al. Neuropsychiatr Dis Treat. 2015 Apr 3;11:967-74. doi: 10.2147/NDT.S80953. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 25897233 Free PMC article.

2

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder.

Atake K, Yoshimura R, Hori H, Katsuki A, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J. Atake K, et al. Clin Psychopharmacol Neurosci. 2014 Apr;12(1):37-40. doi: 10.9758/cpn.2014.12.1.37. Epub 2014 Apr 24. Clin Psychopharmacol Neurosci. 2014. PMID: 24851119 Free PMC article.

3

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites.

Yoshimura R, Kishi T, Iwata N. Yoshimura R, et al. Neuropsychiatr Dis Treat. 2019 Sep 13;15:2655-2661. doi: 10.2147/NDT.S195379. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31686824 Free PMC article.

4

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

Katsuki A, Yoshimura R, Kishi T, Hori H, Umene-Nakano W, Ikenouchi-Sugita A, Hayashi K, Atake K, Iwata N, Nakamura J. Katsuki A, et al. CNS Spectr. 2012 Sep;17(3):155-63. doi: 10.1017/S109285291200051X. Epub 2012 Aug 10. CNS Spectr. 2012. PMID: 22883353

5

Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients.

Zumárraga M, Dávila R, Basterreche N, Arrue A, Goienetxea B, Zamalloa MI, Erkoreka L, Bustamante S, Inchausti L, González-Torres MA, Guimón J. Zumárraga M, et al. Neurochem Int. 2010 May-Jun;56(6-7):774-9. doi: 10.1016/j.neuint.2010.02.015. Epub 2010 Mar 4. Neurochem Int. 2010. PMID: 20206656

6

Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.

Dávila R, Zumárraga M, Basterreche N, Arrúe A, Zamalloa MI, Anguiano JB. Dávila R, et al. J Affect Disord. 2006 Jun;92(2-3):277-81. doi: 10.1016/j.jad.2006.02.009. Epub 2006 Mar 15. J Affect Disord. 2006. PMID: 16542735

7

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study.

Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J. Hayashi K, et al. Neuropsychiatr Dis Treat. 2014 Jun 25;10:1183-90. doi: 10.2147/NDT.S61275. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 25061303 Free PMC article.

8

Association analysis of COMT/MTHFR polymorphisms and major depressive disorder in Chinese Han population.

Shen X, Wu Y, Guan T, Wang X, Qian M, Lin M, Shen Z, Sun J, Zhong H, Yang J, Li L, Yuan Y. Shen X, et al. J Affect Disord. 2014 Jun;161:73-8. doi: 10.1016/j.jad.2014.03.008. Epub 2014 Mar 14. J Affect Disord. 2014. PMID: 24751310

9

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.

Perlis RH, Fijal B, Adams DH, Sutton VK, Trivedi MH, Houston JP. Perlis RH, et al. Biol Psychiatry. 2009 May 1;65(9):785-91. doi: 10.1016/j.biopsych.2008.10.002. Epub 2008 Dec 18. Biol Psychiatry. 2009. PMID: 19095219 Clinical Trial.

10

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study.

Yoshimura R, Kishi T, Atake K, Katsuki A, Iwata N. Yoshimura R, et al. Front Psychiatry. 2018 Feb 28;9:52. doi: 10.3389/fpsyt.2018.00052. eCollection 2018. Front Psychiatry. 2018. PMID: 29541037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year